MYP_153707
Basic Information
P-64
Antimicrobial
Antiviral
Antiviral Anti-HIV Anti-HIV-1
Antiviral Antiviral mechanism Viral fusion inhibition
Standard
25 amino acids
C135H236N36O45
Standard
Sequence
KIEELLKKAEEQQKKNEEELKKLEK
Physicochemical Analysis
3083.53 Da
6.44
-0.23
-0.45
-0.0090
-1.93
0.63
-0.57
81.16
82.00
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1397.55
-10.36
45.0
45.0
123.0
216.0
0.0
27.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0247533 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Acetylation
Amidation
Bio-Activity Profile
Antimicrobial Antiviral
HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells
0.0104±0.0028 μM
IC50
RECORD: Rec_0352126 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Acetylation
Amidation
Bio-Activity Profile
Antimicrobial Antiviral
HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells
0.0093±0.0006 μM
IC50
RECORD: Rec_0358153 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
HR2 fusion-inhibitory peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Acetylation
Amidation
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1 JRCSF | TZM-bl cells
0.0104±0.0028 μM
IC50
Mammalian: 1.3 h; Yeast: 3 min; E. coli: 2 min
Showing 3 records on this page · Page 2 of 2